HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

NATR

Nature's Sunshine Products, Inc.

Consumer Defensive — Packaged Foods

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser. In addition, the company provides weight management products, such as meal replacements and products that increase caloric burn rate. It offers its products under the Nature's Sunshine and Synergy Worldwide brands through its network of independent consultants to customers. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

None 2 analysts
$12.59
$-0.10 (-0.79%)
Target: $34.50 (174.0%)

Price History

52-Week Range
Sign in to add NATR to a watchlist or set price alerts.

Fundamentals

Market Cap$354.34M
P/E Ratio (TTM)18.32
Forward P/E15.21
EPS (TTM)$1.10
Dividend Yield-
Profit Margin4.06%
Revenue Growth8.50%
ROE12.39%
Debt/Equity13.44
Recommendation None
Analyst Target$34.50
Analysts2
Next Earnings Aug 6, 2026 AMC
Indexes -

Technical Indicators

RSI (14)35.3
Beta0.87
SMA 20$20.89
SMA 40$20.73
52-Week High$28.14
52-Week Low$12.97
50-Day Avg$20.87
200-Day Avg$22.28
Avg Volume122.9K
Volume92.0K

Performance Analysis

NEUTRAL

NATR presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($12.97), which could present a value opportunity.
~ RSI at 35.3 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 8.5% year-over-year.
~ Wall Street consensus is "none" from 2 analysts.
+ Average analyst target of $34.50 implies 174.0% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:14 UTC

Back to Screener Export Report